Market Overview:
The global somatostatin acetate market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of pancreatic cancer, increasing demand for minimally invasive surgeries, and growing awareness about the benefits of somatostatin acetate. The global somatostatin acetate market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into ≥98% purity and other. On the basis of application, the market is segmented into acute bleeding, pancreas surgery, and other applications. The North America region dominates the global somatostatin acetate market followed by Europe and Asia Pacific regions respectively.
Product Definition:
Somatostatin Acetate is a hormone that helps to regulate the release of other hormones. It is used to treat certain tumors, including those of the pancreas, and to reduce the amount of sugar in the blood.
≥98% Purity:
Somatostatin Acetate (SSN) is a peptide hormone, which plays an important role in the regulation of several functions including digestion, sleep, reproduction and growth as well as anxiety. SSN has been widely used for decades in the treatment of patients with gastroparesis and chronic diarrhea.
Other:
Other is a peptide hormone, which is released by the brain in response to stress and anxiety. It has been known to have calming effects on the body and mind. The Other also plays a crucial role in regulating appetite, sleep patterns, memory & learning ability along with maintaining body temperature during times of high stress or cold exposure.
Application Insights:
The other application segment includes the use of somatostatin acetate for treating gastrointestinal disorders, such as Crohn¢â‚¬â„¢s disease and pancreatic cancer. The acute bleeding segment held the largest share in 2017 due to high product usage for various types of acute wounds. However, it is anticipated to lose market share over the forecast period due to rising demand from other applications.
Somatostatin acetate is used commonly in surgical procedures involving pancreas because it reduces cell proliferation and causes apoptosis (programmed cell death) in pancreatic tumor cells through a mechanism that involves down-regulation of Akt signaling pathway activity. Somatostatin also inhibits insulin secretion by beta cells, which may lead to reduced blood sugar levels after eating foods containing carbohydrates such as sugars and starch (Ref). Therefore, increasing awareness about its benefits coupled with growing adoption rates are expected drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of manufacturers and suppliers coupled with high healthcare expenditure. The region is expected to maintain its dominance over the forecast period due to increasing approvals by regulatory agencies for new products as well as increased awareness about SSI treatment options.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, improving healthcare infrastructure, and an increase in awareness regarding somatostatin analogues treatment options especially after approval from regulatory authorities. In addition, favorable government initiatives are also expected favorably impact market growth during the forecast period. For instance, Sun Pharma & Cipla’s Lidocaine patch was approved by FDA for acute pain management in adults on October 17th 2018; however it has not been approved yet for use on children under 18 years of age (U.S.).
Growth Factors:
- Increasing prevalence of cancer and other diseases requiring somatostatin therapy
- Growing demand for novel therapies to treat cancer and other diseases
- Rising awareness about the benefits of somatostatin acetate therapy
- Availability of reimbursement for somatostatin acetate therapy
- Technological advancements in the development of new somatostatin analogs
Scope Of The Report
Report Attributes
Report Details
Report Title
Somatostatin Acetate Market Research Report
By Type
≥98% Purity, Other
By Application
Acute Bleeding, Pancreas Surgery, Other
By Companies
ZHEJIANG HUAJUN PHARMACEUTICAL, Zhejiang Peptites Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Somatostatin Acetate Market Report Segments:
The global Somatostatin Acetate market is segmented on the basis of:
Types
≥98% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute Bleeding, Pancreas Surgery, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ZHEJIANG HUAJUN PHARMACEUTICAL
- Zhejiang Peptites Biotech
Highlights of The Somatostatin Acetate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥98% Purity
- Other
- By Application:
- Acute Bleeding
- Pancreas Surgery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Somatostatin Acetate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Somatostatin Acetate is a medication used to treat conditions such as high blood pressure, diabetes, and obesity. It works by reducing the amount of food that is eaten by the body.
Some of the major players in the somatostatin acetate market are ZHEJIANG HUAJUN PHARMACEUTICAL, Zhejiang Peptites Biotech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Somatostatin Acetate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Somatostatin Acetate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Somatostatin Acetate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Somatostatin Acetate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Somatostatin Acetate Market Size & Forecast, 2020-2028
4.5.1 Somatostatin Acetate Market Size and Y-o-Y Growth
4.5.2 Somatostatin Acetate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ≥98% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Acute Bleeding
6.2.2 Pancreas Surgery
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Somatostatin Acetate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Somatostatin Acetate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ≥98% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Acute Bleeding
9.10.2 Pancreas Surgery
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ≥98% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Acute Bleeding
10.10.2 Pancreas Surgery
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ≥98% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Acute Bleeding
11.10.2 Pancreas Surgery
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ≥98% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Acute Bleeding
12.10.2 Pancreas Surgery
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ≥98% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Acute Bleeding
13.10.2 Pancreas Surgery
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Somatostatin Acetate Market: Competitive Dashboard
14.2 Global Somatostatin Acetate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ZHEJIANG HUAJUN PHARMACEUTICAL
14.3.2 Zhejiang Peptites Biotech
